Literature DB >> 30881880

Cardioprotection by very mild hypothermia in mice.

Betül Knoop1,2, David Naguib1,2, Lisa Dannenberg1,2, Carolin Helten1,2, Saif Zako1,2, Christian Jung1,2, Bodo Levkau3, Maria Grandoch4, Malte Kelm1,2, Tobias Zeus1,2, Amin Polzin1,2.   

Abstract

Target temperature management is recommended in post-resuscitation care. Additionally, hypothermia is a promising option in adjunctive therapy of acute myocardial infarction (MI). However, first in men data are contradicting. There are still many open questions to identify the optimal regimen and target temperature. In this study, we aimed to investigate the effect of very mild hypothermia on infarct size (IS) in mice. Mice underwent cardiac ischemia by temporary occlusion of the left anterior descending (LAD) artery under conditions of very mild hypothermia (34-36 °C). Hypothermia was reached within the first 5 minutes of ischemia (temperature: 34.6±0.5 vs. 36.8±1.1 °C, P=0.035). Very mild hypothermia reduced IS in mice undergoing 30 minutes ischemia [IS/area at risk (AAR): 45±12% vs. 22±4%, P=0.018] as well as mice undergoing 60 minutes ischemia [IS/AAR: 67±7% vs. 28±2%, P=0.0003]. Very mild hypothermia reduces IS. This new approach in adjunctive therapy of patients with acute MI should be investigated in clinical trials.

Entities:  

Keywords:  Cardioprotection; hypothermia; infarct size (IS); ischemia/reperfusion; temperature

Year:  2019        PMID: 30881880      PMCID: PMC6382665          DOI: 10.21037/cdt.2018.08.07

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  1 in total

1.  Energy-sparing by 2-methyl-2-thiazoline protects heart from ischaemia/reperfusion injury.

Authors:  Masahiro Nishi; Takehiro Ogata; Ko Kobayakawa; Reiko Kobayakawa; Tomohiko Matsuo; Carlo Vittorio Cannistraci; Shinya Tomita; Shunta Taminishi; Takaomi Suga; Tomoya Kitani; Yusuke Higuchi; Akira Sakamoto; Yumika Tsuji; Tomoyoshi Soga; Satoaki Matoba
Journal:  ESC Heart Fail       Date:  2021-12-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.